111 related articles for article (PubMed ID: 1257276)
1. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
Femmer K; Grünheid K
Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
[No Abstract] [Full Text] [Related]
2. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
Terhaag B; Förster W; Mest HJ; Schrör K
Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
[No Abstract] [Full Text] [Related]
3. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
Diederich KW; Boyksen D
Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
[No Abstract] [Full Text] [Related]
4. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
von Philipsborn G
Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
[No Abstract] [Full Text] [Related]
5. [The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics].
Mertens HM; Schelbert HR; Kreuzer H; Spiller P; Schmiel FK
Arzneimittelforschung; 1973 May; 23(5):642-5. PubMed ID: 4740203
[No Abstract] [Full Text] [Related]
6. [Chronic toxicity of 4-[3'-diethylamino-2'hydroxypropyl]-ajmaline hydrogen tartrate (Tachmalcor) in the rat].
Grimm I; Sziegoleit W; Riedel H; Förster W
Pharmazie; 1976; 31(1):44-7. PubMed ID: 3809
[No Abstract] [Full Text] [Related]
7. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
Terhaag B; Förster W
Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
[No Abstract] [Full Text] [Related]
8. [Structure-activity relationship in various 4-substituted ajmaline derivatives].
Femmer K; Gabsch G; Braun K
Pharmazie; 1976; 31(1):36-9. PubMed ID: 1257277
[No Abstract] [Full Text] [Related]
9. [Action of 17-monochloro-acetylajmaline, a new anti-arrhythmia drug, upon myocardial contractility].
Bardet J; Roudy G; Rocha P; Riguad M; Mathivat A; Bourdarias JP
Ann Cardiol Angeiol (Paris); 1974; 23(6):539-44. PubMed ID: 4618072
[No Abstract] [Full Text] [Related]
10. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L
Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of Norpace.
Dean RR
Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
[No Abstract] [Full Text] [Related]
12. [Antiarrhythmic activity of trimecaine in experimental arrhythmia and its effect on the heart conduction system].
Gendenshteĭn EI; Kostin IaV
Farmakol Toksikol; 1976; 39(4):426-8. PubMed ID: 1027568
[TBL] [Abstract][Full Text] [Related]
13. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
Sano N; Kawada M; Fukutomi Y
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
[No Abstract] [Full Text] [Related]
14. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose.
Nakayama K; Koike H; Oshima T; Hashimoto K
Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270
[No Abstract] [Full Text] [Related]
15. [Comparative study of the effects of various antiarrhythmic drugs on the frequency of ventricular response during established atrial fibrillation].
Bracchetti D; Frabetti L; Mambelli M; Stefanini A; Magnani B
Boll Soc Ital Cardiol; 1977; 22(1):51-5. PubMed ID: 911535
[No Abstract] [Full Text] [Related]
16. [The anti-arrhythmia action of combinations of N-propylajmaline bromide with anti-arrhythmia agents of different classes].
Gendenshteĭn EI; Balashov VP; Kostin IaV; Oleĭnikov VE
Farmakol Toksikol; 1990; 53(1):30-2. PubMed ID: 1691716
[TBL] [Abstract][Full Text] [Related]
17. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
Lisin N; Carlier J
Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497
[No Abstract] [Full Text] [Related]
18. [The antiarrhythmic action mechanism of verapamil (Isoptin)].
Bass O; Friedemann M
Schweiz Med Wochenschr; 1971 May; 101(21):792-9. PubMed ID: 5143469
[No Abstract] [Full Text] [Related]
19. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part II. Thiopental anesthesia.
Orszulak-Michalak D; Trzaskalska M
Pol J Pharmacol; 1995; 47(2):153-62. PubMed ID: 8688888
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
